Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity.
Publication
, Journal Article
Suryadevara, CM; Riccione, KA; Sampson, JH
Published in: Clin Cancer Res
November 1, 2016
Oncolytic viruses, proteasome inhibitors, and natural killer (NK)-cell immunotherapy have all been studied extensively as monotherapies but have never been evaluated in combination. Synergetic treatment of oncolytic virus-infected glioblastomas with a proteasome inhibitor induces necroptotic cell death to enhance NK-cell immunotherapy, prolonging survival against human glioblastoma. Clin Cancer Res; 22(21); 5164-6. ©2016 AACRSee related article by Yoo et al., p. 5265.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Cancer Res
DOI
EISSN
1557-3265
Publication Date
November 1, 2016
Volume
22
Issue
21
Start / End Page
5164 / 5166
Location
United States
Related Subject Headings
- Proteasome Inhibitors
- Oncolytic Viruses
- Oncolytic Virotherapy
- Oncology & Carcinogenesis
- Killer Cells, Natural
- Immunotherapy
- Humans
- Herpesvirus 1, Human
- Glioblastoma
- Cytotoxicity, Immunologic
Citation
APA
Chicago
ICMJE
MLA
NLM
Suryadevara, C. M., Riccione, K. A., & Sampson, J. H. (2016). Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity. Clin Cancer Res, 22(21), 5164–5166. https://doi.org/10.1158/1078-0432.CCR-16-1666
Suryadevara, Carter M., Katherine A. Riccione, and John H. Sampson. “Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity.” Clin Cancer Res 22, no. 21 (November 1, 2016): 5164–66. https://doi.org/10.1158/1078-0432.CCR-16-1666.
Suryadevara CM, Riccione KA, Sampson JH. Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity. Clin Cancer Res. 2016 Nov 1;22(21):5164–6.
Suryadevara, Carter M., et al. “Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity.” Clin Cancer Res, vol. 22, no. 21, Nov. 2016, pp. 5164–66. Pubmed, doi:10.1158/1078-0432.CCR-16-1666.
Suryadevara CM, Riccione KA, Sampson JH. Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity. Clin Cancer Res. 2016 Nov 1;22(21):5164–5166.
Published In
Clin Cancer Res
DOI
EISSN
1557-3265
Publication Date
November 1, 2016
Volume
22
Issue
21
Start / End Page
5164 / 5166
Location
United States
Related Subject Headings
- Proteasome Inhibitors
- Oncolytic Viruses
- Oncolytic Virotherapy
- Oncology & Carcinogenesis
- Killer Cells, Natural
- Immunotherapy
- Humans
- Herpesvirus 1, Human
- Glioblastoma
- Cytotoxicity, Immunologic